Results 161 to 170 of about 324,334 (253)

A retrospective analysis of voluntary adverse event reports to the TGA with higher THC medicinal cannabis products. [PDF]

Aust N Z J Psychiatry
Graham M, Tisdale C, Nielsen S.
europepmc   +1 more source

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas, Matthew E. Sloan, Yaoyi Xing, Ethan Kim, Dhvani Mehta, Anna Mouzenian, Lena C. Quilty, Jeffrey D. Wardell, Shannon Lange, Daniel Felsky, Victor M. Tang   +10 more
wiley   +1 more source

Beyond symptom change: a qualitative descriptive study of reported quality of life experiences among adults prescribed medicinal cannabis for anxiety disorders. [PDF]

Int J Clin Pharm
Roberts L, Cumming C, Budgeon CA, Preen DB, Lee K.   +4 more
europepmc   +1 more source

Medicinal cannabis in Argentina.

Fil: Girodetti, Pablo. Universidad Nacional de Quilmes; Argentina.Fil: Veiga, Ricardo. Universidad Nacional de Quilmes; Argentina.En Argentina, la lucha por el cannabis medicinal avanza desde los años 80, enfrentando represión, estigmas e intereses ...
Girodetti, Pablo, Veiga, Ricardo
core  

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan, Nazli Tunali, R. Andrew Chambers   +2 more
wiley   +1 more source

UK Medical Cannabis Registry: an updated analysis of clinical outcomes of medicinal cannabis therapy for hypermobility-associated chronic pain. [PDF]

Clin Rheumatol
Alemi M, Erridge S, Clarke E, McLachlan K, Coomber R, Barnes S, Darweish Medniuk A, Guru R, Holden W, Sajad M, Searle R, Usmani A, Varma S, Rucker JJ, Platt M, Sodergren MH.   +15 more
europepmc   +1 more source

Proof‐of‐concept trial of PP‐01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Cannabis withdrawal symptoms can be severe and protracted, significantly impeding the ability to abstain from cannabis use, resulting in failed quit attempts and relapse. This clinical trial evaluated safety and efficacy of PP‐01, a novel dual‑mechanism of action, investigational agent, for mitigating cannabis ...
Ashley F. Slagle, Jay Constantine, Harvey Kushner, Shelli Graham, Ginger Constantine   +4 more
wiley   +1 more source

Gambling behaviors associated with problem gambling among patients in treatment for substance use disorder

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Problem gambling impacts substance use disorder (SUD) treatment outcomes. To support early intervention, this study investigated gambling behaviors associated with problem gambling among SUD patients. Methods Patients (N = 593) from 19 residential SUD treatment facilities in California were surveyed about gambling ...
Anna Pagano, Nadra E. Lisha, Jennifer T. Le, Caravella McCuistian   +3 more
wiley   +1 more source

Nanotechnology for the Efficacious Delivery of Medicinal Cannabis and Pharmaceutical Medicines. [PDF]

Pharmaceuticals (Basel)
Vitetta L, Henson JD, Hayes E, Rutolo D, Hall S.   +4 more
europepmc   +1 more source

Electric Scooter‐Related Deaths in Queensland, Australia

ANZ Journal of Surgery, EarlyView.
E‐scooter usage has risen in recent years, and Queensland has seen increasing numbers of e‐scooter‐related deaths. Potential factors associated with these fatal collisions include excessive speed, alcohol intoxication, failure to give way and poor compliance with helmet use.
Nathan Milne, Jack Garland, Rexson Tse, Beng Beng Ong   +3 more
wiley   +1 more source